Nebraska Cancer Specialists - Grand Island — Omaha, Nebraska

Nebraska Cancer Specialists - Grand Island is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialists - Grand Island has participated in 1 clinical trials.

Therapeutic areas: Metastatic Solid Tumors, Non-small Cell Lung Cancer, Melanoma.

Sponsors: Inhibrx Biosciences, Inc.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialists - Grand Island?

Nebraska Cancer Specialists - Grand Island has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialists - Grand Island conducted?

Nebraska Cancer Specialists - Grand Island has 1 clinical trials on record. Their work covers Metastatic Solid Tumors, Non-small Cell Lung Cancer, Melanoma.

Is Nebraska Cancer Specialists - Grand Island accredited by Crixeo Health?

Nebraska Cancer Specialists - Grand Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialists - Grand Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.